Sales 2024 * | 35M 25.56M | Sales 2025 * | 38.7M 28.26M | Capitalization | 110M 80.07M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.13 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.83 x |
P/E ratio 2024 * |
16.9
x | P/E ratio 2025 * |
14.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.63% |
Latest transcript on BioSyent Inc.
Managers | Title | Age | Since |
---|---|---|---|
René C. Goehrum
CEO | Chief Executive Officer | 64 | 95-12-31 |
Robert March
DFI | Director of Finance/CFO | - | 18-09-09 |
Navid Ashrafi
CTO | Chief Tech/Sci/R&D Officer | - | 14-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sara Elford
BRD | Director/Board Member | 53 | 18-01-07 |
René C. Goehrum
CEO | Chief Executive Officer | 64 | 95-12-31 |
Peter Lockhard
BRD | Director/Board Member | 60 | 02-05-31 |
1st Jan change | Capi. | |
---|---|---|
+48.40% | 780B | |
+41.76% | 627B | |
+20.28% | 334B | |
+6.89% | 296B | |
+17.43% | 244B | |
-0.61% | 217B | |
+11.45% | 214B | |
+4.37% | 161B | |
-3.77% | 159B |